Helios

EQS-News: CompuGroup Medical bundles data-based solutions with ambulatory information systems and appoints Daniela Hommel as CFO

Retrieved on: 
Tuesday, October 17, 2023
Physician, Intelligence, Innovation, Helios, Fresenius, CHS, AIS, Artificial intelligence, CGM, KPMG, CFO, Patient, Pharmaceutical industry, Management

Studies show that for every hour doctors and their teams can devote to patients, they spend three to four hours on administrative work.

Key Points: 
  • Studies show that for every hour doctors and their teams can devote to patients, they spend three to four hours on administrative work.
  • AI-based solutions can significantly reduce such inefficiencies in healthcare for the benefit of patients.
  • Also effective as of March 2024, the Board of Directors appoints Daniela Hommel as Chief Financial Officer.
  • Until she joins CompuGroup Medical, CEO Michael Rauch will continue to be responsible for the CFO role on an interim basis.

Helios Launches Cersi, the World's First AI Analyst for the Agricultural Supply Chain; Raises $1.85 Million in Pre-Seed Funding

Retrieved on: 
Tuesday, October 3, 2023
Aldi, Synthetic media, Organization, Fortune 500, Risk, Climate, Weather, AI, Supply, Coca-Cola, Mouth, Cryptocurrency, Renewable energy, Helios, Circe, Microsoft Excel

"Cersi brings something truly unique to the agricultural supply chain space--the ability to ask key questions about your own supply chains and receive insights in seconds. On average, we're seeing the teams that use Cersi increase their productivity by 40%," said Francisco Martin-Rayo, co-founder and CEO of Helios. "The combination of our Supplier Dashboard and Cersi makes us the most impactful solution in this space. Most teams still rely primarily on supplier word of mouth, even when purchasing hundreds of millions of dollars of agricultural products. Imagine, rather than wasting time filling out decks or Excel sheets, and relying on generic and outdated commodity reports, your teams can use our custom insights to prioritize and tackle the most pressing risks in real-time."

Key Points: 
  • Helios has also secured $1.85 million in pre-seed funding led by Supply Change Capital with participation from January Ventures.
  • Helios allows supply chain professionals to detect, evaluate, and proactively mitigate risks that impact their agricultural supply chains.
  • This 360-degree view of supply chain health is driven by billions of data points and centralized into one easy-to-use dashboard.
  • Their industry expertise and strategic guidance will further strengthen Helios' position as a global leader in agricultural and supply chain innovation.

Helius Medical Technologies to Participate at Two Upcoming Healthcare Conferences

Retrieved on: 
Monday, October 2, 2023
HSDT, Helios, Pharmaceutical industry, Nightclub, Risk management

NEWTOWN, Pa., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that Jeff Mathiesen, Chief Financial Officer, will participate at two upcoming conferences as follows:

Key Points: 
  • NEWTOWN, Pa., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that Jeff Mathiesen, Chief Financial Officer, will participate at two upcoming conferences as follows:
    Investors and attendees who would like to schedule a 1-on-1 meeting with Helius management are asked to contact JonesTrading.

Helius Medical Technologies, Inc. Receives UPC Numbers for its PoNS® System and Mouthpiece

Retrieved on: 
Thursday, September 28, 2023
Management of multiple sclerosis, Helios, CMS, GTIN, Pons, HSDT, UPC, Prescription, Pharmacy, Medicare, PBM, Durable medical equipment, Global Trade Item Number, HCPCS, Wolters Kluwer, GameChanger, Health care

NEWTOWN, Pa., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that its Portable Neuromodulation Stimulator (“PoNS®”) system and mouthpiece have been assigned universal product code (“UPC”) numbers by Wolters Kluwer Health – Medi-Span® (“Medi-Span”). Medi-Span is the leading automated clinical screening solution– providing a data backbone and vital support to payers, pharmacy benefit managers (“PBMs”), wholesalers, and manufacturers.

Key Points: 
  • The PoNS system has been assigned the Global Trade Item Number (“GTIN”) of 00864288000462, with a direct price of $25,700.
  • Consequently, this will allow Helius to pursue reimbursement through both the pharmacy and the Durable Medical Equipment (“DME”)/HCPCS pathways.
  • “Receiving UPC numbers for the PoNS system and mouthpiece is a gamechanger for Helius,” said Dane Andreeff, Helius’ President and Chief Executive Officer.
  • "We will now be able to reference these UPC numbers as we negotiate reimbursement with third party payers, and prescriptions can be written with these UPC numbers.

Helios Technologies Extends History of Quarterly Dividends With 107th Consecutive Cash Dividend

Retrieved on: 
Monday, September 25, 2023
Other Manufacturing, Technology, Vehicle Technology, Automotive, General Automotive, Engineering, Automotive Manufacturing, Other Automotive, Manufacturing, Electronic Design Automation, NYSE, Holding company, Helios

Helios Technologies, Inc. (NYSE: HLIO) (“Helios” or the “Company”), a global leader in highly engineered motion control and electronic controls technology for diverse end markets, announced that its Board of Directors declared a quarterly cash dividend of $0.09 per common share.

Key Points: 
  • Helios Technologies, Inc. (NYSE: HLIO) (“Helios” or the “Company”), a global leader in highly engineered motion control and electronic controls technology for diverse end markets, announced that its Board of Directors declared a quarterly cash dividend of $0.09 per common share.
  • Helios has declared consecutive quarterly dividends to its stockholders for over 26 years.
  • The dividend will be payable on October 20, 2023 to stockholders of record as of October 5, 2023.
  • Helios Technologies has approximately 33 million shares of common stock outstanding.

Fortune Media and Great Place To Work Name Helios Technologies’ Operating Company, Enovation Controls, to 2023 Best Workplaces in Manufacturing & Production List

Retrieved on: 
Monday, September 25, 2023
Other Manufacturing, Electronic Design Automation, Automotive, Engineering, Technology, Automotive Manufacturing, General Automotive, Manufacturing, Learning, E-Novation, Multimedia, Organization, NYSE, Great Places, 100 Best Workplaces in Europe, Management, Nursing, Helios

Helios Technologies, Inc. (NYSE: HLIO) (“Helios” or the “Company”), a global leader in highly engineered motion control and electronic controls technology announced its operating company Enovation Controls ranked eleventh on the 2023 list of Best Workplaces in Manufacturing & Production .

Key Points: 
  • Helios Technologies, Inc. (NYSE: HLIO) (“Helios” or the “Company”), a global leader in highly engineered motion control and electronic controls technology announced its operating company Enovation Controls ranked eleventh on the 2023 list of Best Workplaces in Manufacturing & Production .
  • The Best Workplaces in Manufacturing & Production award is based on analysis of survey responses from over 74,000 employees from Great Place To Work Certified™ companies in the manufacturing and production industry.
  • This marks Enovation Controls’ fourth year in a row ranking in the top quartile of the annual list.
  • “Congratulations to the Best Workplaces in Manufacturing & Production,” says Michael C. Bush, CEO of Great Place To Work.

University of Montreal’s School of Rehabilitation to Purchase Ten PoNS® Devices for Research Study on Stroke Recovery

Retrieved on: 
Wednesday, September 20, 2023
Helios, Gait, Pons, HSDT, Stroke, Research, Rehabilitation, Patient, Risk, School, United, Falling, Pharmaceutical industry

NEWTOWN, Pa., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced it has signed an agreement with the School of Rehabilitation at the Université de Montréal (“UdeM”) for the purchase of ten PoNS devices to be used in a research project linked to stroke recovery.

Key Points: 
  • NEWTOWN, Pa., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced it has signed an agreement with the School of Rehabilitation at the Université de Montréal (“UdeM”) for the purchase of ten PoNS devices to be used in a research project linked to stroke recovery.
  • “We are excited to work with UdeM’s School of Rehabilitation to explore further the benefits of using PoNS Therapy during a stroke patient’s recovery journey.
  • Since March 2023, PoNS has been authorized in Canada to treat gait deficit due to mild and moderate symptoms from stroke, and the body of clinical evidence shows that patients treated with PoNS experience significant improvement in gait and a reduced risk of falling,” said Antonella Favit-Van Pelt, M.D., Ph.D., Helius' Chief Medical Officer.
  • “UdeM’s study will provide Helius important information about how PoNS Therapy can be best utilized to help those suffering from stroke and will also serve as another step forward in pursuing market access for stroke in the United States.”

Helios Technologies Launches Next-Generation Premium Rugged Display-Controller – The PowerView™ P70 – with Initial Customer

Retrieved on: 
Monday, September 18, 2023
Other Manufacturing, Electronic Design Automation, Automotive, Engineering, Technology, Automotive Manufacturing, General Automotive, Manufacturing, GPS, Wi-Fi, E-Novation, Original equipment manufacturer, Shock, Electronics, Multimedia, Hearing, Water, Dust, Bluetooth, Nit, Glass, NYSE, Barber Pro Series, Video game, Helios, P70

Helios Technologies , Inc. (NYSE: HLIO) (“Helios” or the “Company”), a global leader in highly engineered motion control and electronic controls technology for diverse end markets, has unveiled the new PowerView™ P70 , as part of the all-new Pro Series, Helios’ next-generation of premium rugged display-controllers.

Key Points: 
  • Helios Technologies , Inc. (NYSE: HLIO) (“Helios” or the “Company”), a global leader in highly engineered motion control and electronic controls technology for diverse end markets, has unveiled the new PowerView™ P70 , as part of the all-new Pro Series, Helios’ next-generation of premium rugged display-controllers.
  • "With its combination of advanced features, premium display quality, and rugged durability, the PowerView™ P70 is the perfect solution for both powersports and industrial customers who demand the best.
  • This is another great example of Helios leveraging a new platform across more than one end market to achieve a multiplier effect.
  • Customers and prospects can view the new PowerView™ P70 at The Utility Expo September 26 - 28, 2023 in booth #3241.

Hunting PLC (“Hunting” or “the Company” or “the Group”) Capital Markets Day

Retrieved on: 
Wednesday, September 13, 2023
Engineering, Other Energy, Utilities, Oil, Gas, Manufacturing, Energy, Other Manufacturing, Carbon, Subsea technology, Paternoster Square, Capital market, London Stock Exchange, Strategic alliance, CNOOC, Aviation, Advanced manufacturing, IP, Energy transition, Vedanta Limited, Corrosion, Gulf of Mexico, Education minister, United Kingdom, Growth, Alloy, Renewable energy, Security (finance), Shipbuilding, Titan, Helios, Electronics, Hunting, Dearborn, CCUS

In May 2023, Hunting won a $91m order from Cairn Oil and Gas, Vedanta Limited.

Key Points: 
  • In May 2023, Hunting won a $91m order from Cairn Oil and Gas, Vedanta Limited.
  • Trading within Hunting Titan has been resilient, despite the decline in the North America onshore rig count this year.
  • Hunting is a global engineering group that provides precision-engineered equipment and premium services, which add value for our customers.
  • The Group reports in US dollars across five operating segments: Hunting Titan; North America; Subsea Technologies; Europe, Middle East and Africa (“EMEA”) and Asia Pacific.

Picogrid Announces Helios: Smallest AI-Enabled Command Station Deployable in Minutes

Retrieved on: 
Wednesday, September 13, 2023
Pentagon, Communication, Army, United States Department of Defense, Fort Leonard Wood, ISR, SATCOM, Internet, MP, Air force, The, Joint, AI, Family, Conference, Defender, Electric battery, Telescopic sight, Communications satellite, Helios

EL SEGUNDO, Calif., Sept. 13, 2023 /PRNewswire/ -- Today, Picogrid, a defense technology firm, took the wraps off its latest innovation: Helios. This state-of-the-art hardware will be in the spotlight at the U.S. Army Military Police Regimental Association Conference at Fort Leonard Wood, MO.

Key Points: 
  • Contained within a single, man-portable hard-shell case, Helios is a rapidly deployable platform that integrates high-bandwidth multi-network communications, onboard computing, and sensor capabilities.
  • Helios is engineered specifically for the unique challenges associated with remote operations, a timely solution relevant for areas like the Pacific Island Chains.
  • The users can connect ISR sensors and mobile devices to DoD networks within minutes anywhere in the world.
  • This new product comes on the heels of Picogrid's recent $950 million contract win for the Joint All-Domain Command and Control (JADC2) initiative.